SCHEMBL7005884

SCHEMBL7005884

CCOC(=O)c1[nH]c(N)c(C(=O)OCC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.50
HPGD P15428 7/20 0.50
MAPT P10636 5/20 0.50
GAA P10253 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 2/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
FHIT P49789 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMT2A Q03164 4/20 0.45
POLB P06746 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MEN1 O00255 2/20 0.44
MAPK1 P28482 2/20 0.44
HSD17B10 Q99714 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7056712 0.79 CYP1A2 (0.54) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL7480180 0.76 HPGD (0.51) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL5598196 0.76 HPGD (0.49) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL8053715 0.75 CYP1A2 (0.68) ALDH1A1HPGDMAPTSMN1; SMN2KDM4E
SCHEMBL3550531 0.73 HPGD (0.56) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL9208540 0.72 HPGD (0.51) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL7006136 0.72 RAB9A (0.52) ALDH1A1MAPTSMN1; SMN2KDM4EHTT
SCHEMBL9898080 0.71 HPGD (0.69) ALDH1A1HPGDMAPTSMN1; SMN2KDM4E
SCHEMBL25212786 0.71 MAPT (0.50) ALDH1A1HPGDMAPTGAASMN1; SMN2
SCHEMBL2390518 0.69 ALDH1A1 (0.67) ALDH1A1HPGDMAPTGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363910-A2 METHODS OF TREATING P38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2003-11-26 EP disclosed
EP-1183033-A4 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL MYERS SQUIBB CO (US) 2002-07-17 EP disclosed
WO-2002040486-A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-05-23 WO disclosed
EP-1183033-A1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-03-06 EP disclosed
WO-2000071129-A1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-30 WO disclosed